MRC1 and neoplasm: Emodin treatment (40 mg/kg, i.p) did not alter the tumor size and weight, but suppressed macrophage infiltration in the tumors (particularly CD206+ M2-like macrophages), increased CD4+ and CD8+ T cells, and decreased the expression of Vimentin and MMP9.